XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 941 $ 57,617 $ 337,752 $ 113 $ 396,423 $ 28,827 $ 425,250
Common shares outstanding at Dec. 31, 2021 9,411,028            
 Stock option grant compensation $ 0 34 0 0 34 0 34
 Exercise of stock options 1 232 0 0 233 0 233
 Restricted stock compensation 0 292 0 0 292 0 292
 Restricted stock award 2 (2) 0 0 0 0 0
 Forfeiture of restricted stock award 0 0 0 0 0 0 0
Shares purchased and canceled             0
 Shares granted to Directors $ 1 649 0 0 650 0 650
Director shares granted 11,232            
 Net income $ 0   1,329 0 1,329 (343) 986
 Distributions to partners 0   0 0 0 (1,349) (1,349)
Minimum pension liability             0
 Unrealized loss on investment, net $ 0   0 (1,209) (1,209) 0 (1,209)
Stock options exercised 11,870            
 Shares granted to Employees $ 0 50 0 0 50 0 50
Shares granted to Employee 865            
Restricted shares awarded 21,464            
Restricted stock forfeited (1,363)            
Ending balance, value at Jun. 30, 2022 $ 945 58,872 339,081 (1,096) 397,802 27,135 424,937
Common shares outstanding at Jun. 30, 2022 9,455,096            
Beginning balance, value at Dec. 31, 2021 $ 941 57,617 337,752 113 396,423 28,827 425,250
Common shares outstanding at Dec. 31, 2021 9,411,028            
Ending balance, value at Dec. 31, 2022 $ 946 65,158 342,317 (1,276) 407,145 37,066 $ 444,211
Common shares outstanding at Dec. 31, 2022 9,459,686           9,459,686
Beginning balance, value at Mar. 31, 2022 $ 943 57,812 338,424 (737) 396,442 27,788 $ 424,230
Common shares outstanding at Mar. 31, 2022 9,431,994            
 Stock option grant compensation $ 0 17 0 0 17 0 17
 Exercise of stock options 1 232 0 0 233 0 233
 Restricted stock compensation 0 162 0 0 162 0 162
 Restricted stock award             0
 Forfeiture of restricted stock award             0
Shares purchased and canceled             0
 Shares granted to Directors $ 1 649 0 0 650 0 650
Director shares granted 11,232            
 Net income $ 0   657 0 657 (75) 582
 Distributions to partners 0   0 0 0 (578) (578)
Minimum pension liability             0
 Unrealized loss on investment, net $ 0   0 (359) (359) 0 (359)
Stock options exercised 11,870            
Ending balance, value at Jun. 30, 2022 $ 945 58,872 339,081 (1,096) 397,802 27,135 424,937
Common shares outstanding at Jun. 30, 2022 9,455,096            
Beginning balance, value at Dec. 31, 2022 $ 946 65,158 342,317 (1,276) 407,145 37,066 $ 444,211
Common shares outstanding at Dec. 31, 2022 9,459,686           9,459,686
 Stock option grant compensation $ 0 33 0 0 33 0 $ 33
 Exercise of stock options 2 801 0 0 803 0 803
 Restricted stock compensation 0 518 0 0 518 0 518
 Restricted stock award 2 (2) 0 0 0 0 0
 Forfeiture of restricted stock award             0
Shares purchased and canceled $ (1) (129) (870) 0 (1,000) 0 (1,000)
Stock Repurchased During Period, Shares (18,340)            
 Shares granted to Directors $ 1 599 0 0 600 0 600
Director shares granted 10,380            
 Net income $ 0 0 1,163 0 1,163 (265) 898
 Distributions to partners 0 0 0 0 0 (1,685) (1,685)
Minimum pension liability 0 0 0 (16) (16) 0 (16)
 Unrealized loss on investment, net $ 0 0 0 580 580 0 580
Stock options exercised 17,735            
 Shares granted to Employees $ 0 50 0 0 50 0 50
Shares granted to Employee 928            
Restricted shares awarded 25,284            
Ending balance, value at Jun. 30, 2023 $ 950 67,028 342,610 (712) 409,876 35,116 $ 444,992
Common shares outstanding at Jun. 30, 2023 9,495,673           9,495,673
Beginning balance, value at Mar. 31, 2023 $ 950 66,281 342,882 (902) 409,211 35,974 $ 445,185
Common shares outstanding at Mar. 31, 2023 9,503,633            
 Stock option grant compensation $ 0 16 0 0 16 0 16
 Exercise of stock options             0
 Restricted stock compensation 0 261 0 0 261 0 261
 Restricted stock award             0
 Forfeiture of restricted stock award             0
Shares purchased and canceled $ (1) (129) (870) 0 (1,000) 0 (1,000)
Stock Repurchased During Period, Shares (18,340)            
 Shares granted to Directors $ 1 599 0 0 600 0 600
Director shares granted 10,380            
 Net income $ 0 0 598 0 598 (106) 492
 Distributions to partners 0 0 0 0 0 (752) (752)
Minimum pension liability 0 0 0 (16) (16) 0 (16)
 Unrealized loss on investment, net 0 0 0 206 206 0 206
Ending balance, value at Jun. 30, 2023 $ 950 $ 67,028 $ 342,610 $ (712) $ 409,876 $ 35,116 $ 444,992
Common shares outstanding at Jun. 30, 2023 9,495,673           9,495,673